PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.2800
0.00 (0.00%)
Aug 27, 2026, 4:08 PM HKT
PuraPharm Corporation Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 323.49 | 336.11 | 382.09 | 406.86 | 448.07 | 659.59 |
Revenue Growth | -3.75% | -12.03% | -6.09% | -9.20% | -32.07% | 9.60% |
Gross Profit Gross Profit Growth | 177.35 | 180.16 | 205.14 | 216.63 | 262.7 | 423.35 |
Operating Income Operating Income Growth | -11.3 | -16.22 | -18.25 | -53.2 | -68.25 | 15.14 |
Net Income Net Income Growth | -27.66 | -35.22 | -35.44 | -106.08 | -120.21 | -121.88 |
Earnings Per Share EPS Growth | -0.06 | -0.08 | -0.09 | -0.27 | -0.30 | -0.31 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Hong Kong CCMG Hong Kong CCMG Growth | 204.95 | 212.49 | 215.47 | 199.41 | 170.64 |
Chinese Healthcare Products Chinese Healthcare Products Growth | 96.97 | 85.91 | 83.58 | 79.28 | 79.09 |
Clinics Clinics Growth | 51.24 | 56.31 | 53.73 | 46.11 | 50.03 |
Plantation Plantation Growth | 175.97 | 183.98 | 37.61 | 89.53 | 44.83 |
Elimination Elimination Growth | -193.01 | -156.59 | -156.33 | -208.51 | -136.05 |
Total Total Growth | 336.11 | 382.09 | 406.86 | 448.07 | 659.59 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12.23 | 35.9 | 36.9 | 42.98 | 91.36 | 96.06 |
Total Debt Total Debt Growth | 370.62 | 351.14 | 363.76 | 424.77 | 503.16 | 531.96 |
Net Cash (Debt) Net Cash Growth | -358.39 | -315.25 | -326.86 | -381.8 | -411.8 | -435.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.73 | -0.75 | -0.83 | -0.97 | -1.04 | -1.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -4.72 | 28.53 | 103.99 | 79.61 | 88.51 | -14.52 |
Capital Expenditures CapEx Growth | -1.76 | -0.28 | -14.81 | -19.18 | -20.83 | -3.09 |
Free Cash Flow Free Cash Flow Growth | -6.48 | 28.24 | 89.18 | 60.43 | 67.68 | -17.61 |
Free Cash Flow Growth | - | -68.33% | 47.58% | -10.72% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.82% | 53.60% | 53.69% | 53.24% | 58.63% | 64.18% |
Operating Margin | -3.49% | -4.83% | -4.78% | -13.08% | -15.23% | 2.30% |
Pretax Margin | -8.60% | -10.24% | -7.63% | -25.15% | -26.60% | -17.77% |
Profit Margin | -8.55% | -10.48% | -9.28% | -26.07% | -26.83% | -18.48% |
FCF Margin | -2.00% | 8.40% | 23.34% | 14.85% | 15.10% | -2.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 13.33 | 13.33 | 13.33 | 13.33 | 13.33 |
P/FCF Ratio | - | 6.73 | 2.44 | 5.88 | 7.47 | - |
PS Ratio | 0.46 | 0.56 | 0.57 | 0.87 | 1.13 | 0.48 |